|
A.
VAX-D
is covered by most insurance policies either in part or in full. TLC
Medical Group can arrange a finance plan to cover any portion of the
treatment that is not covered by your insurance carrier.
If
you compare the cost of VAX-D to surgery you will find that VAX-D Is less
than 20% of the cost. This huge saving does not include other costs that
accompany the surgery such as prolonged physical rehabilitation. These
savings are appreciated by our patients as well as their insurance
companies.
A.
Most
patients with low back pain syndrome achieve relief while undergoing
treatment and require an average of one session per day, five days a week,
for six weeks. This comes to a total of approximately thirty sessions to
attain remission of debilitating symptoms.
The
actual number of sessions depends on the severity of the patient's
underlying condition. For example, patients with herniated discs generally
respond within twenty to forty sessions while patients with degenerated
discs often achieve significant relief with the same number of sessions
but may need ongoing treatment at regular intervals to remain pain free.
On
the other hand, patients with posterior facet syndrome usually achieve
complete remission with fewer than twenty sessions. The more severe the
patient's overall condition the greater the number of sessions that may be
required.
|
|
A.
Experience
has shown the majority of patients that recover on VAX-D generally remain
in remission. However, some individuals whose lifestyle or work
environment tends to expose them to higher risk factors or who suffer from
severe disc degeneration have found that a maintenance program, consisting
of one or two treatment sessions per month on the VAX-D
Table, offers a measure of protection against disabling exacerbations of
their low back pain. Patients in this category tend to develop their own
rhythm of maintenance visits that keep them relatively free of pain.
A.
VAX-D
has been used as a follow-up treatment for patients that continue to
complain of post-surgical low back pain. This is especially true in those
patients that have more than one level of herniation in which only the
major segment was removed.
A.
The
VAX-D
Table is an FDA licensed medical device and the treatment has worked on
thousands of patients. VAX-D is
too new to have become a household name. In addition, many family doctors
are unaware of VAX-D
and its effectiveness for the treatment of serious low back pain. This
lack of awareness is changing. More and more physicians and health care
providers are learning about VAX-D
and the phenomenal results it has achieved in the various clinical
studies. Furthermore, VAX-D received its own insurance code on January 1,
1999. The awareness of VAX-D
seems to increase everyday and we expect VAX-D
to be the standard of care for serious low back pain in the not too
distant future.
|